Breakthroughs in scientific research and a growing body of evidence show that an oral probiotic strain, Streptococcus salivarius K12, can help protect against bacterial infections of the respiratory tract caused by COVID-19 and other respiratory viruses, making it a new weapon in the fight against infectious disease.
Alternative therapies and protections are necessary because of the incomplete protection offered by COVID-19 vaccines, which fail to block infection or prevent transmission and may cause vaccine injury, including death.
